Rita Patwardhan

2.6k total citations
14 papers, 2.0k citations indexed

About

Rita Patwardhan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Hematology. According to data from OpenAlex, Rita Patwardhan has authored 14 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Hematology. Recurrent topics in Rita Patwardhan's work include Peroxisome Proliferator-Activated Receptors (8 papers), Diabetes Treatment and Management (8 papers) and Metabolism, Diabetes, and Cancer (7 papers). Rita Patwardhan is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Diabetes Treatment and Management (8 papers) and Metabolism, Diabetes, and Cancer (7 papers). Rita Patwardhan collaborates with scholars based in United States, United Kingdom and Italy. Rita Patwardhan's co-authors include Elizabeth B. Rappaport, Martin I. Freed, Jo Dole, J Rosenstock, Andrew L. Salzman, Vivian Fonseca, Harold E. Lebovitz, N. P. Jones, George Grunberger and Lawrence S. Phillips and has published in prestigious journals such as JAMA, Blood and Gastroenterology.

In The Last Decade

Rita Patwardhan

14 papers receiving 1.9k citations

Peers

Countries citing papers authored by Rita Patwardhan

Since Specialization

Citations

This map shows the geographic impact of Rita Patwardhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Patwardhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Patwardhan more than expected).

Fields of papers citing papers by Rita Patwardhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Patwardhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Patwardhan. The network helps show where Rita Patwardhan may publish in the future.

Co-authorship network of co-authors of Rita Patwardhan

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Patwardhan. A scholar is included among the top collaborators of Rita Patwardhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Patwardhan. Rita Patwardhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy 2013 ·Gastroenterology ·Nezam H. Afdhal, Geoffrey Dusheiko, Edoardo G. Giannini, Pei‐Jer Chen, Kwang‐Hyub Han, Aftab Mohsin, M. Rodríguez‐Torres, Sorin Rugină, И. Г. Бакулин, Eric Lawitz, Mitchell L. Shiffman, (unknown), Fred Poordad, Yasser Mostafa Kamel, Andrés Brainsky, James Geib, Sandra Y. Vasey, Rita Patwardhan, Fiona Campbell, Dickens Theodore	98
2	Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide 2013 ·BMC Cancer ·Sant P. Chawla, Arthur P. Staddon, (unknown), Conrad A. Messam, Rita Patwardhan, (unknown)	21
3	60 RESULTS OF ENABLE 2, A PHASE 3, MULTICENTER STUDY OF ELTROMBOPAG AND PEGINTERFERON ALFA-2B TREATMENT IN PATIENTS WITH HEPATITIS C AND THROMBOCYTOPENIA 2012 ·Journal of Hepatology ·Geoffrey Dusheiko, Nezam H. Afdhal, Edoardo G. Giannini, (unknown), Kwang‐Hyub Han, M. Rodríguez‐Torres, Sorin Rugină, E. Läwitz, Adrian Streinu‐Cercel, (unknown), F. Poordad, (unknown), Andrés Brainsky, James Geib, (unknown), Rita Patwardhan, (unknown), Dickens Theodore	4
4	FINAL RESULTS OF ENABLE 1, A PHASE 3, MULTICENTER STUDY OF ELTROMBOPAG AS AN ADJUNCT FOR ANTIVIRAL TREATMENT OF HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASE ASSOCIATED WITH THROMBOCYTOPENIA 2011 ·UCL Discovery (University College London) ·Nezam H. Afdhal, Geoffrey Dusheiko, Edoardo G. Giannini, Pei‐Jer Chen, Kwang‐Hyub Han, (unknown), M. Rodríguez‐Torres, Sorin Rugină, Eric Lawitz, (unknown), (unknown), F. Poordad, (unknown), Andrés Brainsky, James Geib, (unknown), Rita Patwardhan, (unknown), Dickens Theodore	12
5	Final Results of Open-Label Treatment with Eltrombopag During ENABLE 1: A Study of Eltrombopag As An Adjunct for Antiviral Treatment of Hepatitis C Virus Associated with Thrombocytopenia 2011 ·Blood ·Geoffrey Dusheiko, Nezam H. Afdhal, Edoardo G. Giannini, Pei‐Jer Chen, Kwang‐Hyub Han, Yasser Mostafa Kamel, Andrés Brainsky, James Geib, Sandra Y. Vasey, Rita Patwardhan, Fiona Campbell, Dickens Theodore	4
6	A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors 2010 ·Current Medical Research and Opinion ·(unknown), Agnieszka Jagiełło-Gruszfeld, Igor Bondarenko, Rita Patwardhan, (unknown), Yasser Mostafa Kamel	46
7	A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes 2006 ·Nutrition Metabolism and Cardiovascular Diseases ·M Hanefeld, Rita Patwardhan, Nigel C. Jones	31
8	A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes 2002 ·Diabetes Care ·Martin St. John Sutton, Marc Rendell, Paresh Dandona, Jo Dole, Karen Murphy, Rita Patwardhan, Jai Patel, Martin I. Freed	213
9	Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Harold E. Lebovitz, Jo Dole, Rita Patwardhan, Elizabeth B. Rappaport, Martin I. Freed	432
10	Once- and Twice-Daily Dosing With Rosiglitazone Improves Glycemic Control in Patients With Type 2 Diabetes 2001 ·Diabetes Care ·Lawrence S. Phillips, George Grunberger, Elizabeth R. Miller, Rita Patwardhan, Elizabeth B. Rappaport, Alan Salzman	255
11	Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus 2000 ·Diabetic Medicine ·John J. Nolan, N. P. Jones, Rita Patwardhan, (unknown)	99
12	Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus 2000 ·JAMA ·Vivian Fonseca, J Rosenstock, Rita Patwardhan, Andrew L. Salzman	435
13	Addition of low‐dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients 2000 ·Diabetic Medicine ·Bruce H. R. Wolffenbuttel, Ramón Gomis, Sebastiano Squatrito, N. P. Jones, Rita Patwardhan	205
14	Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes 2000 ·Diabetologia ·Philip Raskin, Elizabeth B. Rappaport, (unknown), Yizhong Yan, Rita Patwardhan, Martin I. Freed	181

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact